Poseida Therapeutics to Present at Two Upcoming Investor Conferences
Poseida Therapeutics(US:PSTX) Prnewswire·2024-11-11 21:05SAN DIEGO, Nov. 11, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments for patients with cancer, autoimmune and rare diseases, today announced that the Company will participate in the following upcoming investor conferences:Stifel 2024 Healthcare ConferenceDate: Monday, November 18, 2024Time: 10:20am ETPiper Sandler 36th Annual Healthcare ConferenceDate: Wednesday, December 4, 20 ...